Skip to main content
logo
Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.34915
+0.0002 (0.04%)
Nov 6, 2026, 4:00 PM EST - Market closed

Oragenics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---0.040.130.09
Revenue Growth
----71.37%51.20%-
Cost of Revenue
3.422.394.1115.4910.0710.59
Gross Profit
-3.42-2.39-4.11-15.45-9.94-10.5
Selling, General & Admin
7.056.976.445.454.485.27
Other Operating Expenses
-----0
Operating Expenses
7.056.976.445.454.485.27
Operating Income
-10.47-9.36-10.56-20.9-14.42-15.77
Interest Expense
-0.02-0.79-0.03-0.03-0.02-0.02
Interest & Investment Income
0.230.180.050.210.140.08
Currency Exchange Gain (Loss)
-0.03-0.01-0.03---
Other Non Operating Income (Expenses)
---0.070.010
EBT Excluding Unusual Items
-10.29-9.98-10.57-20.66-14.29-15.71
Pretax Income
-10.29-9.98-10.57-20.66-14.29-15.71
Income Tax Expense
-0.21-0.14----
Earnings From Continuing Operations
-10.08-9.84-10.57-20.66-14.29-15.71
Net Income
-10.08-9.84-10.57-20.66-14.29-15.71
Net Income to Common
-10.08-9.84-10.57-20.66-14.29-15.71
Net Income Growth
------
Shares Outstanding (Basic)
420000
Shares Outstanding (Diluted)
420000
Shares Change
714.58%877.24%194.38%11.97%3.40%106.24%
EPS (Basic)
-2.51-4.56-47.88-275.48-213.36-242.59
EPS (Diluted)
-2.51-4.56-47.88-275.48-213.36-242.59
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-10.21-9.25-8.6-7.29-15.36-13.51
Free Cash Flow Per Share
-2.54-4.29-38.95-97.23-229.30-208.66
Operating Margin
----55519.89%-10964.61%-18131.88%
Profit Margin
----54858.14%-10863.96%-18062.03%
Free Cash Flow Margin
----19363.34%-11675.70%-15535.76%
EBITDA
---10.53-20.88-14.38-15.73
D&A For EBITDA
--0.030.030.040.04
EBIT
-10.47-9.36-10.56-20.9-14.42-15.77
SEC Filings: 10-K · 10-Q